Trademark: 90610911
Status Date
Monday, October 17, 2022
Filing Date
Monday, March 29, 2021
Published for Opposition
Tuesday, January 18, 2022
Abandoned Date
Monday, October 17, 2022
5 therapeutic preparations for the treatment of respiratory diseases and disorders; therapeutic preparations for the treatment of COVID-19; therapeutic preparations, namely, antibodies for the purpose of targeting the CCR5 cell receptor of cells and inhibiting or blocking the channel signaling of the CCR5 cell receptor for medical treatment
Oct 17, 2022
Abandonment Notice E-Mailed - No Use Statement Filed
Oct 17, 2022
Abandonment - No Use Statement Filed
Mar 15, 2022
Noa E-Mailed - Sou Required From Applicant
Jan 18, 2022
Official Gazette Publication Confirmation E-Mailed
Jan 18, 2022
Published For Opposition
Dec 29, 2021
Notification Of Notice Of Publication E-Mailed
Dec 13, 2021
Approved For Pub - Principal Register
Dec 9, 2021
Teas/Email Correspondence Entered
Dec 8, 2021
Correspondence Received In Law Office
Dec 8, 2021
Teas Response To Office Action Received
Dec 4, 2021
Notification Of Priority Action E-Mailed
Dec 4, 2021
Priority Action E-Mailed
Dec 4, 2021
Priority Action Written
Nov 18, 2021
Assigned To Examiner
Jul 6, 2021
New Application Office Supplied Data Entered
Apr 1, 2021
New Application Entered
Trademark Alertz updated from USPTO on 2030-01-24
